A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
PHASE3
This phase III trial compares standard chemotherapy to therapy with liposom...
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
PHASE2
This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates...
Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)
PHASE2
This phase II MyeloMATCH treatment trial compares cytarabine versus (vs.) c...